Loading clinical trials...
Loading clinical trials...
This study will collect information from patients with Alagille syndrome (ALGS) as they use odevixibat (Bylvay) in their daily lives. Odevixibat is a medicine that helps patients with ALGS, a rare di...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ipsen
NCT05035030 · Alagille Syndrome
NCT07293897 · Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT05543174 · Alagille Syndrome (ALGS)
NCT02963077 · Orphan Cholestatic Liver Diseases, Primary Biliary Cirrhosis, and more
NCT02047318 · Alagille Syndrome
Childrens Hospital Los Angeles
Los Angeles, California
UCSF Pediatric Gastroenterology
San Francisco, California
The Children's Mercy Hospital
Kansas City, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions